Interview with Rizobacter’s CEO, Ricardo Yapur

Rizobacter launches a new specialty fertilizer product line called Microstar BIO, where biologicals are combined with a chemical fertilizer

Biological control is used to reduce the incidence of pests and diseases, by using natural enemies. Due to their different modes of action, bioprotectors ensure protection efficiency and minimize disease tolerance. They can be used alternatively or complementarily with main chemically synthesized seed treatments.

GILBERT, AZ (January 18, 2021) Heliae® Agriculture announced today a new strategic collaboration with Rizobacter, a subsidiary of Bioceres Crop Solutions Corp., a global leader in sustainable solutions for agriculture.

By Susana Solá -Head of Research and Seeds Quality at Rizobacter

Within the framework of a strengthening alliance, Syngenta has incorporated Rizoderma Soja (Soybean) technology into its seed treatment products portfolio. Tested for more than 10 years in different extensive crops, this biofungicide is gaining ground in Argentina and in the world.

September 15th, 2020, Pergamino, Argentina/ Davis, CA, USA. -- Rizobacter, a subsidiary of Bioceres Crop Solutions Corp. (NYSE: BIOX) and global leader in sustainable solutions for agriculture, and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced the signing of an exclusive agreement to distribute a foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia.

As of this winter cereal season, Syngenta will include in its seed treatment products portfolio a biofungicide developed by Rizobacter and the National Institute of Agricultural Technology (INTA).

Buenos Aires, March 18th. It’s probably that this is not a well-known datum, but 21% of the global inoculants market is held by an Argentine company, Rizobacter.

The company was founded in 1977 in Pergamino City, the heart of the Pampas, by a small group of entrepreneurs. One of them is Ricardo Yapur, current vice-president after Bioceres Group acquired 50.01% of the shares in 2016.